Role of activator protein-1 on the effect of arginine-glycine-aspartic acid containing peptides on transforming growth factor-β1 promoter activity
Authors:
- M.P. Ruiz-TorresMRM.P. Ruiz-Torres
- G. Perez-RiveroGPG. Perez-Rivero
- M.L. Diez-MarquesMDM.L. Diez-Marques
- M. GrieraMGM. Griera
- R. OrtegaROR. Ortega
- M. Rodriguez-PuyolMRM. Rodriguez-Puyol
- D. Rodríguez-PuyolDRD. Rodríguez-Puyol
- 1 January 2007
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (1) , 133-145
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A novel RGDS-analog inhibits angiogenesis in vitro and in vivoBiochemical and Biophysical Research Communications, 2004
- RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cellsBlood, 2004
- Novel Platelet InhibitorsAnnual Review of Medicine, 2001
- Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinaseProceedings of the National Academy of Sciences, 1998
- Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcuminOncogene, 1998
- Regulation of Human Interstitial Collagenase (Matrix Metalloproteinase‐1) Promoter Activity by Fibroblast Growth FactorEuropean Journal of Biochemistry, 1997
- A synthetic inhibitor of the mitogen-activated protein kinase cascade.Proceedings of the National Academy of Sciences, 1995
- Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responsesBiochemical Journal, 1993
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991